Home › Funds › Versant Venture Management, LLC › GLUE

Versant Venture Management, LLC position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

Versant Venture Management, LLC reported holding 3,180,780 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$37.9M, representing 34.78% of its reported portfolio and ranking #1 among its reported holdings. Versant Venture Management, LLC has disclosed GLUE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)3.18M sh
Reported value held$37.95M
Portfolio Weight34.78%
First reportedQ4 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Versant Venture Management, LLC's GLUE position evolved

Versant Venture Management, LLC first disclosed a stake in GLUE in Q4 2024 at 5,652,922 shares (US$39.2M). The position peaked in Q2 2026 at 3,180,780 shares, worth US$77.0M. Across 8 filings, Versant Venture Management, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 3,180,780 shares valued at US$37.9M. Notable position changes include a 27% trim in Q1 2026 (shares rose 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 5.65M $39.23M New
Q1 2025 5.65M $26.23M Hold
Q2 2025 5.65M $25.49M Hold
Q3 2025 5.65M $41.89M Hold
Q4 2025 4.38M $68.72M Reduce
Q1 2026 3.18M $52.32M Reduce
Q2 2026 3.18M $76.97M Hold
Q3 2026 3.18M $37.95M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 62 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has Versant Venture Management, LLC held GLUE?

Versant Venture Management, LLC has disclosed GLUE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Versant Venture Management, LLC's current position in GLUE?

As of Q3 2026, Versant Venture Management, LLC holds 3.18M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $37.95M, representing 34.78% of its reported portfolio and ranking #1.

Has Versant Venture Management, LLC been buying or selling GLUE?

In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in GLUE. The position peaked in Q2 2026 at 3.18M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.